22.418 articles found

Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?

Zand R.

Eur Neurol · 2008-01-29

DOI: 10.1159/000114040PMID: 18230877

Therapeutic effects of Delta9-THC and modafinil in a marmoset Parkinson model.

van Vliet SA, Vanwersch RA, Jongsma MJ, Olivier B, Philippens IH.

Eur Neuropsychopharmacol · 2008-01-28

DOI: 10.1016/j.euroneuro.2007.11.003PMID: 18222654

Should levodopa dose be reduced when switched to stalevo?

Linazasoro G, Kulisevsky J, Hernández B, Spanish Stalevo Study Group.

Eur J Neurol · 2008-01-22

DOI: 10.1111/j.1468-1331.2007.02047.xPMID: 18215153

Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice.

Oki C, Watanabe Y, Yokoyama H, Shimoda T, Kato H, Araki T.

Cell Mol Neurobiol · 2008-01-17

DOI: 10.1007/s10571-007-9241-2PMID: 18204968

Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.

Stack EC, Ferro JL, Kim J, Del Signore SJ, Goodrich S, Matson S, Hunt BB, Cormier K, Smith K, Matson WR, Ryu H, Ferrante RJ.

Biochim Biophys Acta · 2008-01-16

DOI: 10.1016/j.bbadis.2007.12.006PMID: 18206128

Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.

Yamada K, Goto S, Hamasaki T, Kuratsu JI.

Acta Neurochir (Wien) · 2008-01-10

DOI: 10.1007/s00701-007-1451-3PMID: 18180867

Severe mitral valve regurgitation with fatal cardiogenic shock in a patient on long-term cabergoline treatment.

Luedde M, Helmke B, Katus HA, Frey N.

Int J Cardiol · 2008-01-09

DOI: 10.1016/j.ijcard.2007.11.043PMID: 18191474

TREATMENT OF CNS DISORDERS ASSOCIATED WITH MUTATIONS IN GENES ENCODING LYSOSOMAL ENZYMES

WUSTMAN BRANDON.

· 2008-01-07

PHARMACEUTICAL COMPOSITIONS CONTAINING THE CATECHOL AND ITS DERIVATIVES FOR USE IN THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES

SUK KYOUNG HO, ZHENG LONG TAI, KWON BYOUNG MOG.

· 2008-01-03

Oscillatory activity in the basal ganglia : is it relevant to movement disorders and their therapy?

Chen CC.

· 2008-01-01

Development of an electronic treatment decision aid for Parkinson's disease using mutli-criteria decision analysis

Cunningham C.

· 2008-01-01

[Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors].

Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D.

Nervenarzt · 2008-01-01

DOI: 10.1007/s00115-007-2312-2PMID: 17687535